URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Michael J. Harrington net worth and biography

Michael Harrington Biography and Net Worth

Director of Elanco Animal Health

Michael J. Harrington has served as a member of the Elanco Board of Directors since September 2018.

Mike Harrington serves as senior vice president and general counsel for Eli Lilly and Company.

Since joining Lilly, he has served as managing director of the New Zealand affiliate and as associate general counsel for Lilly’s operations in the Asia-Pacific region, as well as other business and legal positions. Previously, Harrington was vice president and general counsel of global pharmaceutical operations. In this capacity, he was responsible for legal issues related to Lilly’s five global business units.

Harrington currently serves as the board chair for the Indiana Repertory Theatre and the co-chair of the Civil Justice Reform Group. He is also a member of the board of trustees and executive committee of Albion College. He earned a bachelor’s degree in English from Albion College and a law degree from the Columbia University School of Law.

What is Michael J. Harrington's net worth?: The estimated net worth of Michael J. Harrington is at least $436,125.00 as of December 6th, 2024. Mr. Harrington owns 37,500 shares of Elanco Animal Health stock worth more than $436,125 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Harrington may own. Learn More about Michael J. Harrington's net worth.
How do I contact Michael J. Harrington?: The corporate mailing address for Mr. Harrington and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on Michael J. Harrington's contact information.
Has Michael J. Harrington been buying or selling shares of Elanco Animal Health?: Michael J. Harrington has not been actively trading shares of Elanco Animal Health over the course of the past ninety days. Most recently, on Thursday, August 22nd, Michael J. Harrington bought 3,500 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $14.85 per share, with a total value of $51,975.00. Following the completion of the transaction, the director now directly owns 81,094 shares of the company's stock, valued at $1,204,245.90. Learn More on Michael J. Harrington's trading history.
Who are Elanco Animal Health's active insiders?: Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Rajeev Modi (Insider), Jeffrey Simmons (President & CEO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.
Are insiders buying or selling shares of Elanco Animal Health?: During the last year, Elanco Animal Health insiders bought shares 4 times. They purchased a total of 138,500 shares worth more than $1,930,475.00. The most recent insider tranaction occured on August, 22nd when Director Michael J Harrington bought 3,500 shares worth more than $51,975.00. Insiders at Elanco Animal Health own 0.6% of the company. Learn More about insider trades at Elanco Animal Health.
Information on this page was last updated on 8/22/2024.

Michael J. Harrington Insider Trading History at Elanco Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/22/2024	Buy	3,500	$14.85	$51,975.00	81,094
8/11/2021	Buy	3,000	$28.98	$86,940.00	25,684
3/9/2020	Buy	4,000	$23.84	$95,360.00	16,799
4/17/2019	Buy	142,000	$0.01	$1,420.00	12,546,012

Michael J. Harrington Buying and Selling Activity at Elanco Animal Health

Elanco Animal Health Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Today's Range

Now: $11.63

$11.63

$12.19

50 Day Range

MA: $12.96

$11.63

$14.50

2 Week Range

Now: $11.63

$11.40

$18.80

Volume

9,435,554 shs

Average Volume

4,797,913 shs

Market Capitalization

$5.75 billion

P/E Ratio

29.08

Dividend Yield

N/A

Beta

1.41

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now